IL-1 inhibits β-adrenergic control of cardiac calcium current: Role of L- arginine/nitric oxide pathway

G. J. Rozanski, R. C. Witt

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Modulation of the β-adrenergic control of cardiac L-type Ca2+ current (I(Ca)) by human recombinant interleukin-1β (IL-1) was examined in adult guinea pig ventricular myocytes using the whole cell voltage-clamp technique. I(Ca) was elicited in Cs+-loaded myocytes by depolarizing pulses from a holding potential of -40 mV. Isoproterenol (0.01 and 1 μM) exposed to myocytes pretreated with 1 ng/ml IL-1 evoked a significantly smaller increase in I(Ca) density compared with control cells. This IL-1-mediated decrease in β-responsiveness was usually observed with pretreatment periods of > 1 h and varied as a function of the L-arginine concentration of the pretreatment medium. In addition, it was prevented by 1) IL-1 receptor antagonist, 2) substituting D-arginine for L-arginine, or 3) incubating cells with the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine. Thus the present data illustrate that IL-1 significantly alters the β-adrenergic control of cardiac Ca2+ channels by cellular mechanisms that involve the activation of nitric oxide synthase. These mechanisms may play a role in altering ventricular function during cytokine-mediated inflammatory processes affecting the heart.

Original languageEnglish (US)
Pages (from-to)H1753-H1758
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume267
Issue number5 36-5
StatePublished - Jan 1 1994

Fingerprint

interleukin-1
Interleukin-1
Adrenergic Agents
nitric oxide
arginine
Arginine
Nitric Oxide
Muscle Cells
Calcium
calcium
myocytes
Nitric Oxide Synthase
nitric oxide synthase
pretreatment
Interleukin-1 Receptors
Ventricular Function
Patch-Clamp Techniques
patch-clamp technique
Isoproterenol
cells

Keywords

  • channels
  • cytokines
  • nitric oxide synthase

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

IL-1 inhibits β-adrenergic control of cardiac calcium current : Role of L- arginine/nitric oxide pathway. / Rozanski, G. J.; Witt, R. C.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 267, No. 5 36-5, 01.01.1994, p. H1753-H1758.

Research output: Contribution to journalArticle

@article{0fc7977a41ee4691869d827134605ca2,
title = "IL-1 inhibits β-adrenergic control of cardiac calcium current: Role of L- arginine/nitric oxide pathway",
abstract = "Modulation of the β-adrenergic control of cardiac L-type Ca2+ current (I(Ca)) by human recombinant interleukin-1β (IL-1) was examined in adult guinea pig ventricular myocytes using the whole cell voltage-clamp technique. I(Ca) was elicited in Cs+-loaded myocytes by depolarizing pulses from a holding potential of -40 mV. Isoproterenol (0.01 and 1 μM) exposed to myocytes pretreated with 1 ng/ml IL-1 evoked a significantly smaller increase in I(Ca) density compared with control cells. This IL-1-mediated decrease in β-responsiveness was usually observed with pretreatment periods of > 1 h and varied as a function of the L-arginine concentration of the pretreatment medium. In addition, it was prevented by 1) IL-1 receptor antagonist, 2) substituting D-arginine for L-arginine, or 3) incubating cells with the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine. Thus the present data illustrate that IL-1 significantly alters the β-adrenergic control of cardiac Ca2+ channels by cellular mechanisms that involve the activation of nitric oxide synthase. These mechanisms may play a role in altering ventricular function during cytokine-mediated inflammatory processes affecting the heart.",
keywords = "channels, cytokines, nitric oxide synthase",
author = "Rozanski, {G. J.} and Witt, {R. C.}",
year = "1994",
month = "1",
day = "1",
language = "English (US)",
volume = "267",
pages = "H1753--H1758",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "5 36-5",

}

TY - JOUR

T1 - IL-1 inhibits β-adrenergic control of cardiac calcium current

T2 - Role of L- arginine/nitric oxide pathway

AU - Rozanski, G. J.

AU - Witt, R. C.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Modulation of the β-adrenergic control of cardiac L-type Ca2+ current (I(Ca)) by human recombinant interleukin-1β (IL-1) was examined in adult guinea pig ventricular myocytes using the whole cell voltage-clamp technique. I(Ca) was elicited in Cs+-loaded myocytes by depolarizing pulses from a holding potential of -40 mV. Isoproterenol (0.01 and 1 μM) exposed to myocytes pretreated with 1 ng/ml IL-1 evoked a significantly smaller increase in I(Ca) density compared with control cells. This IL-1-mediated decrease in β-responsiveness was usually observed with pretreatment periods of > 1 h and varied as a function of the L-arginine concentration of the pretreatment medium. In addition, it was prevented by 1) IL-1 receptor antagonist, 2) substituting D-arginine for L-arginine, or 3) incubating cells with the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine. Thus the present data illustrate that IL-1 significantly alters the β-adrenergic control of cardiac Ca2+ channels by cellular mechanisms that involve the activation of nitric oxide synthase. These mechanisms may play a role in altering ventricular function during cytokine-mediated inflammatory processes affecting the heart.

AB - Modulation of the β-adrenergic control of cardiac L-type Ca2+ current (I(Ca)) by human recombinant interleukin-1β (IL-1) was examined in adult guinea pig ventricular myocytes using the whole cell voltage-clamp technique. I(Ca) was elicited in Cs+-loaded myocytes by depolarizing pulses from a holding potential of -40 mV. Isoproterenol (0.01 and 1 μM) exposed to myocytes pretreated with 1 ng/ml IL-1 evoked a significantly smaller increase in I(Ca) density compared with control cells. This IL-1-mediated decrease in β-responsiveness was usually observed with pretreatment periods of > 1 h and varied as a function of the L-arginine concentration of the pretreatment medium. In addition, it was prevented by 1) IL-1 receptor antagonist, 2) substituting D-arginine for L-arginine, or 3) incubating cells with the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine. Thus the present data illustrate that IL-1 significantly alters the β-adrenergic control of cardiac Ca2+ channels by cellular mechanisms that involve the activation of nitric oxide synthase. These mechanisms may play a role in altering ventricular function during cytokine-mediated inflammatory processes affecting the heart.

KW - channels

KW - cytokines

KW - nitric oxide synthase

UR - http://www.scopus.com/inward/record.url?scp=0028043855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028043855&partnerID=8YFLogxK

M3 - Article

C2 - 7526712

AN - SCOPUS:0028043855

VL - 267

SP - H1753-H1758

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 5 36-5

ER -